业绩报告

Search documents
亚势备份发布中期业绩,净亏损18.1万港元,同比收窄85.1%
Zhi Tong Cai Jing· 2025-08-08 11:45
Core Viewpoint - The company reported a revenue of HKD 18.9 million for the six months ending June 30, 2025, representing a year-on-year decline of 8.2% while net loss narrowed to HKD 181,000, a reduction of 85.1% [1] Financial Performance - Revenue for the period was HKD 18.9 million, down 8.2% compared to the previous year [1] - The net loss was HKD 181,000, significantly reduced by 85.1% year-on-year [1] - Basic loss per share was HKD 0.01 [1] Factors Influencing Performance - The reduction in loss was primarily due to increased foreign exchange gains from the appreciation of foreign currency bank balances [1] - Optimized market strategies led to a decrease in marketing and advertising expenses [1] - A reduction in average employee numbers contributed to lower employee costs [1] - However, the revenue from online backup services was negatively impacted by the overall weakness in the global economy and reduced demand for the company's services [1]
煌上煌:上半年营收同比下降7.2%,归母净利润同比增长26.9%
Bei Jing Shang Bao· 2025-08-07 12:55
公司在2025年半年度报告中提到,其主要业务未发生重大变化,继续专注于酱卤肉制品及米制品的研 发、生产和销售。报告期内,行业内竞争加剧,导致公司在门店拓展方面未达预期,部分老店单店收入 持续下降。 此外,报告指出公司在原材料价格方面受益于市场价格低位,主要原材料如鸭脖、鸭翅等 的采购成本有所下降,从而带动了酱卤肉制品的综合毛利率稳步回升。 北京商报讯(记者 郭秀娟 实习记者 王悦彤) 8月7日,煌上煌公布2025年半年报,报告期内,公司实现 营业收入9.84亿元,同比下降7.2%;实现归母净利润7692万元,同比上升26.9%;实现扣非归母净利润 为6810万元,同比上升40.3%;经营现金流净额为2.03亿元,同比增长21.7%。分季度来看,在第二季 度,公司实现营业收入5.38亿元,同比下降10.7%;实现归母净利润3255万元,同比上升16.1%;实现扣 非归母净利润2862万元,同比上升30.6%。截至二季度末,公司总资产为33.13亿元,较上年度末增长 0.9%;归母净资产为27.73亿元,较上年度末增长0.7%。 ...
煌上煌: 2025年半年度报告摘要
Zheng Quan Zhi Xing· 2025-08-07 10:15
江西煌上煌集团食品股份有限公司 2025 年半年度报告摘要 证券代码:002695 证券简称:煌上煌 公告编号:2025—028 江西煌上煌集团食品股份有限公司 江西煌上煌集团食品股份有限公司 2025 年半年度报告 摘要 一、重要提示 本半年度报告摘要来自半年度报告全文,为全面了解本公司的经营成果、财务状况及未来发展规划,投 资者应当到证监 会指定媒体仔细阅读半年度报告全文。 所有董事均已出席了审议本报告的董事会会议。 非标准审计意见提示 □适用 ?不适用 董事会审议的报告期利润分配预案或公积金转增股本预案 □适用 ?不适用 公司计划不派发现金红利,不送红股,不以公积金转增股本。 董事会决议通过的本报告期优先股利润分配预案 □适用 ?不适用 二、公司基本情况 股票简称 煌上煌 股票代码 002695 股票上市交易所 深圳证券交易所 联系人和联系方式 董事会秘书 证券事务代表 姓名 曾细华 万明琪 江西省南昌市南昌县小蓝经济开发区 江西省南昌市南昌县 小蓝经济开发区 办公地址 洪州大道 66 号 洪州大道 66 号 电话 0791-85985546 0791-85985546 电子信箱 596130616@q ...
煌上煌:上半年净利润7691.99万元,同比增长26.9%
Zheng Quan Shi Bao Wang· 2025-08-07 10:06
Core Viewpoint - The company reported a decline in revenue but an increase in net profit for the first half of 2025, indicating improved operational efficiency despite challenging market conditions [1] Financial Performance - The company's revenue for the first half of 2025 was 984 million yuan, a year-on-year decrease of 7.19% [1] - The net profit attributable to shareholders was 76.92 million yuan, reflecting a year-on-year increase of 26.9% [1] Cost Management - The prices of key raw materials, including duck wings, duck necks, and frozen duck products, remained low during the reporting period [1] - The comprehensive gross profit margin for the company's marinated meat products increased by 2.23 percentage points year-on-year [1] - Sales expenses decreased significantly, with a year-on-year decline of 27.38%, attributed to reduced labor costs and marketing expenditures [1]
煌上煌:2025年上半年净利润7691.99万元,同比增长26.90%
Xin Lang Cai Jing· 2025-08-07 09:58
煌上煌公告,2025年上半年营业收入9.84亿元,同比下降7.19%。净利润7691.99万元,同比增长 26.90%。公司计划不派发现金红利,不送红股,不以公积金转增股本。 ...
容百科技(688005.SH)发布上半年业绩,由盈转亏至6839.46万元
智通财经网· 2025-08-01 11:26
Core Insights - Rongbai Technology (688005.SH) reported a revenue of 6.248 billion yuan for the first half of 2025, representing a year-on-year decrease of 9.28% [1] - The net loss attributable to shareholders of the listed company was 68.3946 million yuan, with a net loss of 79.3053 million yuan after excluding non-recurring gains and losses [1] - The basic loss per share was 0.1 yuan [1] Revenue Analysis - The decline in revenue is primarily attributed to significant fluctuations in the prices of key raw materials, which led to adjustments in product pricing [1]
藏格矿业(000408.SZ)发布上半年业绩,归母净利润18亿元,增长38.80%
智通财经网· 2025-08-01 11:20
Core Viewpoint - Cangge Mining (000408.SZ) reported a decrease in operating revenue for the first half of 2025, while net profit showed significant growth, indicating a mixed performance influenced by market conditions and pricing dynamics in the potassium chloride sector [1] Financial Performance - The company's operating revenue was 1.678 billion yuan, a year-on-year decrease of 4.74% [1] - Net profit attributable to shareholders was 1.8 billion yuan, reflecting a year-on-year increase of 38.80% [1] - The net profit after deducting non-recurring gains and losses was 1.808 billion yuan, up 41.55% year-on-year [1] - Basic earnings per share were 1.1526 yuan [1] - The company proposed a cash dividend of 10 yuan (including tax) for every 10 shares to all shareholders [1] Production and Sales - The company achieved potassium chloride production of 485,200 tons and sales of 535,900 tons, meeting 48.52% and 56.41% of the annual targets, respectively [1] - The average selling price of potassium chloride (including tax) was 2,845 yuan per ton, a year-on-year increase of 25.57% [1] - The average sales cost was 996 yuan per ton, showing a year-on-year decrease of 7.36% [1] Revenue and Profitability - The revenue from potassium chloride was 1.399 billion yuan, an increase of 24.60% year-on-year [1] - The gross profit margin was 61.84%, reflecting a year-on-year increase of 13.56% [1]
北京文化(000802.SZ)发布上半年业绩,归母净亏损2.33亿元,扩大610.29%
智通财经网· 2025-08-01 10:55
智通财经APP讯,北京文化(000802.SZ)发布2025年半年度报告,该公司营业收入为1.58亿元,同比增长 1944.24%。归属于上市公司股东的净亏损为2.33亿元,同比扩大610.29%。归属于上市公司股东的扣除 非经常性损益的净亏损为2.44亿元,同比扩大576.57%。基本每股亏损为0.325元。 ...
东方雨虹发布上半年业绩,归母净利润5.64亿元,下降40.16%
智通财经网· 2025-07-31 14:06
智通财经APP讯,东方雨虹(002271.SZ)发布2025年半年度报告,该公司营业收入为135.69亿元,同比减 少10.84%。归属于上市公司股东的净利润为5.64亿元,同比减少40.16%。归属于上市公司股东的扣除非 经常性损益的净利润为5.07亿元,同比减少39.33%。基本每股收益为0.24元。此外,拟向全体股东每10 股派发现金红利9.25元(含税)。 2025年上半年,公司实现工程渠道及零售渠道收入共计114.06亿元,占公司营业收入比例为84.06%,渠 道销售收入占比进一步提升,目前已成为公司主要的销售模式。 ...
香港电讯上半年净利逾20亿港元 青岛银行中期盈利同比增逾一成
Xin Lang Cai Jing· 2025-07-31 12:41
Performance Updates - 开拓药业-B (09939.HK) has completed patient enrollment for the Phase III clinical trial of KX-826 solution for androgenetic alopecia in adult males in China [2] - 李氏大药厂 (00950.HK) has received approval from the National Medical Products Administration for Socazolimab to be used in combination with chemotherapy for first-line treatment of extensive-stage small cell lung cancer in mainland China [2] - 恒瑞医药 (01276.HK) has received approval for clinical trials of SHR-8068 injection, Adebali monoclonal antibody injection, and Bevacizumab injection [2] - 恒瑞医药 (01276.HK) has also received approval to conduct clinical trials for HRS-5041, intended for prostate cancer treatment [2] - 深圳高速公路股份 (00548.HK) reported toll revenue of 106 million yuan for the outer ring project in June [2] - 大成生化科技 (00809.HK) has signed an EPC contract with Northeast Electric and Liaoning Electric for boiler renovation projects, with a maximum cost of 129.1 million yuan [2] - 小黄鸭德盈 (02250.HK) has signed a contract to develop an AI marketing system to diversify revenue sources [2] Buyback and Financing Activities - 威海银行 (09677.HK) plans to issue up to approximately 758 million domestic shares and 154 million H-shares, raising nearly 3 billion yuan [2] Financial Results - 香港电讯-SS (06823.HK) reported total revenue of 17.322 billion HKD for the first half, a year-on-year increase of 4%, with a net profit of 2.07 billion HKD, also up 4% [4] - 青岛银行 (03866.HK) reported operating revenue of 7.662 billion yuan for the first half, a growth of 7.5%, and a net profit of 3.065 billion yuan, up 16.05% [4] - 中国石油化工股份 (00386.HK) expects mid-term net profit to be between 20.1 billion and 21.6 billion yuan, a year-on-year decline of 39.5%-43.7% [4] - 汽车之家-S (02518.HK) reported total revenue of 3.212 billion yuan for the first half, a decrease of 7.75%, with a net profit of 772 million yuan, down 15.99% [4] - 绿茶集团 (06831.HK) issued a profit warning, expecting mid-term net profit to be between 230 million and 237 million yuan, a year-on-year increase of approximately 32%-36% [4] - 粤海置地 (00124.HK) issued a profit warning, expecting mid-term net profit to exceed 260 million HKD, turning from loss to profit [4] - 药师帮 (09885.HK) issued a profit warning, expecting mid-term net profit to exceed 70 million yuan [4] - 中国东方教育 (00667.HK) issued a profit warning, expecting mid-term net profit to grow by 45%-50% year-on-year [4] - 中核国际 (02302.HK) issued a profit warning, expecting mid-term revenue to increase to at least 585 million HKD, with net profit of at least 9.5 million HKD [4] - 大唐环境 (01272.HK) issued a profit warning, expecting mid-term net profit to decrease to between 350 million and 400 million yuan [4] - 长江生命科技 (00775.HK) issued a profit warning, expecting mid-term net loss of approximately 150 million HKD, turning from profit to loss year-on-year [4] - 延长石油国际 (00346.HK) issued a profit warning, expecting mid-term loss of approximately 27.9 million HKD [4]